Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 10.11 Jasper Therapeutics, Inc. Employee Severance Plan for Vice Presidents and Executive Committee Members
- 10.12 Jasper Therapeutics, Inc. 2019 Equity Incentive Plan
- 10.21 Material Transfer Agreement, Dated December 14, 2020, by and Between Jasper Therapeutics, Inc. and Zai Lab Limited
- 10.22 Intramural Clinical Trial Agreement, Executed February 11, 2021, by and Between Jasper Therapeutics, Inc. and National Heart, Lung, and Blood Institute, Part of the National Institutes of Health
- 10.28 Form of Indemnification Agreement by and Between Jasper Therapeutics, Inc. and Each of Its Directors and Executive Officers
- 10.29 Consulting Agreement, Dated December 16, 2019, by and Between Jasper Therapeutics, Inc. and Judith Shizuru, M.D., PH.D
- 23.2 Consent of Independent Registered Public Accounting Firm
- 23.3 Consent of Withumsmith+brown, PC
- 99.1 Form of Proxy for Stockholders of Amplitude Healthcare Acquisition Corporation
- 99.6 Consent of Christian W. Nolet to Be Named As Director
- Download Excel data file
- View Excel data file
Associated filings
- 27 Aug 21 EFFECT Notice of effectiveness
- 26 Aug 21 424B3 Prospectus supplement
- 25 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 20 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 9 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
16 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Jun 21 S-4 Registration of securities issued in business combination transactions
JSPR similar filings
Filing view
External links